Entering text into the input field will update the search result below

Beam posts preclinical data showing potential of LNP delivery method in base editing

Sep. 23, 2021 7:33 AM ETBeam Therapeutics Inc. (BEAM) StockNTLABy: Dulan Lokuwithana, SA News Editor1 Comment

Abstract luminous DNA molecule. Genetic and gene manipulation concept. Cut of replacing part of a DNA molecule. Medicine. Innovative in science. Medical science and biotechnology.
ipopba/iStock via Getty Images

  • Beam Therapeutics (NASDAQ:BEAM) is trading ~3.2% higher in the pre-market on low volume after the company reported preclinical data to support the potential of its novel lipid nanoparticle (LNP) delivery approach for in vivo

Recommended For You

About BEAM Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
BEAM--
Beam Therapeutics Inc.